{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002379","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"EGAX00001304977","attributes":{"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K4me3"],"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["20 min; 30 sec ON/ 30 sec OFF"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20  ul"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0  ug"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33  ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["164"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/23977/Multiple_Myeloma/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"1.2M","NAME":"S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151015.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/23977/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151015.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"6f803293af6c908901fd9133bd2081fd"},{"FORMAT":"BED","SIZE":"1.3M","NAME":"S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151015.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/23977/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151015.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"7314ef72f107c3058ccc89c9712e5393"},{"FORMAT":"Text","SIZE":"1.5M","NAME":"S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151015.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/23977/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151015.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"06ec52450257e7eb77a9efb0aeb7d875"},{"FORMAT":"bigWig","SIZE":"528M","NAME":"S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151029.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/bone_marrow/23977/Multiple_Myeloma/ChIP-Seq/NCMLS/S00XEIH1.ERX1007377.H3K4me3.bwa.GRCh38.20151029.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"ed4567f1913eca83deb7a1b20dc6f128"}],"dataset_id":"EGAD00001002379","sample":{"SAMPLE_SOURCE":"bone marrow","SAMPLE_NAME":"23977","sample_barcode":"S00XEIH1","attributes":{"DISEASE":["Multiple Myeloma"],"TREATMENT":["NA"],"CELL_TYPE":["plasma cell"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0026764"}],"SAMPLE_ONTOLOGY_URI":[{"url":"6","label":"CL_0000786"}],"GENDER":["female"],"DONOR_ID":["23977"],"PASSAGE_IF_EXPANDED":["NA"],"MARKERS":["CD138+"],"DONOR_HEALTH_STATUS":["Multiple Myeloma"],"MOLECULE":["genomic DNA"],"DONOR_AGE":["65 - 70"],"BIOMATERIAL_PROVIDER":["Felipe Prosper in collaboration with Jose I. Martin-Subero, University of Navarra"],"TISSUE_TYPE":["bone marrow"],"BIOMATERIAL_TYPE":["Primary Cell"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001276793","SAMPLE_DESCRIPTION":"Multiple Myeloma"}}